Wolverine Asset Management LLC INTERCEPT PHARMACEUTICALS IN Transaction History

Wolverine Asset Management LLC

$4.35 Billion
Q3 2024

Shares

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 13, 2021	SELL	N/A	-3,133,000 Closed	0 $0
Q1 2021 May 13, 2021	SELL	N/A	-29,950,000 Reduced 90.53%	3,133,000 $2.6 Million
Q4 2020 Feb 12, 2021	SELL	N/A	-37,282,000 Reduced 52.98%	33,083,000 $25.8 Million
Q2 2020 Aug 13, 2020	BUY	N/A	1,500,000 Added 2.18%	70,365,000 $52.5 Million
Q1 2020 May 13, 2020	BUY	N/A	18,100,000 Added 35.65%	68,865,000 $56 Million
Q4 2019 Feb 14, 2020	BUY	N/A	5,426,000 Added 11.97%	50,765,000 $51.4 Million
Q3 2019 Nov 14, 2019	BUY	N/A	2,703,000 Added 6.34%	45,339,000 $39.2 Million
Q2 2019 Aug 14, 2019	BUY	N/A	25,043,000 Added 142.35%	42,636,000 $38 Million
Q1 2019 May 15, 2019	SELL	N/A	-990,000 Reduced 5.33%	17,593,000 $17.5 Million
Q4 2018 Feb 14, 2019	BUY	N/A	635,000 Added 3.54%	18,583,000 $17.3 Million
Q3 2018 Nov 14, 2018	BUY	N/A	17,948,000 New	17,948,000 $18.1 Million
Q4 2017 Feb 14, 2018	SELL	N/A	-10,487,000 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	N/A	-32,000,000 Reduced 75.32%	10,487,000 $8.14 Million
Q2 2017 Aug 14, 2017	BUY	N/A	42,487,000	42,487,000 $41.4 Million

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.